Oncologists' cost-effectiveness thresholds for new cancer therapies

被引：0
|
作者：
Nadler, E
Eckert, B
Neumann, P
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Boston, MA 02115 USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62576-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
  • [31] Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients
    Woldemichael, Andinet
    Onukwugha, Eberechukwu
    Seal, Brian
    Hanna, Nader
    Mullins, C. Daniel
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (06): : 628 - 639
  • [32] A survey of US and Canadian oncologists' attitudes toward the cost, cost-effectiveness (CE), and reimbursement of cancer drugs
    Neumann, P.
    Berry, S. R.
    Nadler, E.
    Evans, W. C.
    Palmer, J.
    Bell, C.
    Strevel, E.
    Fang, H.
    Ubel, P. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer
    Benedict, A
    Brown, RE
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (11) : 1789 - 1801
  • [34] An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer
    Gogate, Anagha
    Rotter, Jason S.
    Trogdon, Justin G.
    Meng, Ke
    Baggett, Christopher D.
    Reeder-Hayes, Katherine E.
    Wheeler, Stephanie B.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 343 - 355
  • [35] An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer
    Anagha Gogate
    Jason S. Rotter
    Justin G. Trogdon
    Ke Meng
    Christopher D. Baggett
    Katherine E. Reeder-Hayes
    Stephanie B. Wheeler
    [J]. Breast Cancer Research and Treatment, 2019, 174 : 343 - 355
  • [36] COST-EFFECTIVENESS IN CANCER
    FITZPATRICK, PJ
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1974, 111 (07) : 652 - 653
  • [37] COST-EFFECTIVENESS AND BUDGET IMPACT OF NEW THERAPIES FOR METASTATIC MELANOMA IN ITALY
    Pompilio, G.
    Campanella, P.
    Integlia, D.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A425 - A425
  • [38] Use of cost-effectiveness analysis to guide the clinical implementation of new therapies
    Pérez, FXB
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (12): : 1377 - 1380
  • [39] Cost-effectiveness of novel therapies for overactive bladder
    Mayr, Craig A.
    Shepherd, Jonathan P.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (04) : 527 - 535
  • [40] Assessing the cost-effectiveness of emerging therapies in the ICU
    Chalfin, DB
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 20 (03) : 263 - 270
12345